<DOC>
	<DOCNO>NCT01849107</DOCNO>
	<brief_summary>Small bowel irradiation result epithelial cell loss consequently impair function metabolism . A metabolic end product small bowel enterocytes plasma citrulline . The investigator evaluate correlation plasma citrulline level , dose-volume histogram small bowel , small bowel toxicity grade Common Terminology Criteria Adverse Events version 4.0 ( CTCAE ver.4.0 ) investigate whether citrulline use biomarker quantify radiation-induced epithelial cell loss .</brief_summary>
	<brief_title>Plasma Citrulline : A Marker Monitoring &amp; Quantifying Radiation-Induced Small Bowel Toxicity</brief_title>
	<detailed_description />
	<criteria>Histologically confirm cancer patient Appropriate liver , renal , bone marrow function radiotherapy Willing provide inform write consent At least 20 year old prior abdominopelvic radiation therapy chemotherapy abdominal surgery Any contraindication radiotherapy ( i.e . Severe connective tissue disorder , etc . ) Prior simultaneous history malignancy On medication small bowel disease CTCAE 4.0 Grade 1 high toxicity radiation Any treatment delay 1 week radiotherapy No radiotherapy due reason except small bowel toxicity</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Radiation-induced small bowel toxicity</keyword>
	<keyword>Plasma citrulline</keyword>
</DOC>